82 results
UPLOAD
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
8 Oct 20
Letter from SEC
12:00am
to be recurring in nature since you reported similar costs in
the comparable
periods. Please tell us how you considered the guidance in Item 10(e … as unusual when the nature of the charge or
gain is such that it is
reasonably likely to recur within two years or there was a similar
charge or gain
DRSLTR
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
14 Oct 20
Correspondence regarding draft registration statement
12:00am
to be recurring in nature since you reported similar costs in the comparable periods. Please tell us how you considered the guidance in Item 10(e … ) of Regulation S-K which prohibits adjusting a non-GAAP financial performance measure to eliminate or smooth items identified as unusual when the nature
S-1
EX-10.16
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
29 Oct 20
IPO registration
5:04pm
, encumbrances or security interests of any kind or nature to attach to the Licensed Property during the Term. Otherwise, Tenant shall surrender the Licensed … from all claims, demands, actions, judgments, liabilities, costs, expenses, losses, damages, penalties, fines and obligations of any nature (including
DRS/A
EX-10.16
sm0913pl1h8
14 Oct 20
Draft registration statement (amended)
12:00am
8-K
EX-10.1
mbe5z 091fp
3 Sep 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.6
qfbpjt14
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
8-K
EX-99.1
pt3v wd95a
28 Jan 22
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
8:03am
DRSLTR
82qyuzzk da4
23 Oct 20
Correspondence regarding draft registration statement
12:00am
8-K
EX-2.1
hx7zdr2v1t mdi2zebl
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
DRS/A
EX-10.18
y5tl2ag1akyqfgwko4w
14 Oct 20
Draft registration statement (amended)
12:00am